Reports for MINT PHARMACEUTICALS INC
Company Name
MINT PHARMACEUTICALS INC
Totals |
||
Shortage reports |
132 |
|
Actual shortage: | 30 (23%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 0 (0%) | |
Resolved: | 102 (77%) | |
Discontinuation Reports |
29 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 29 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
33 (20%) |
|
Overdue reports |
15 (50%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2018-04-12 | 2018-05-08 | 45536 |
MINT-CITALOPRAM | 40MG | TABLET | Resolved | 2018-04-12 | 2018-05-16 | 45533 |
MINT-AMLODIPINE | 10MG | TABLET | Resolved | 2018-04-12 | 2018-05-29 | 45528 |
MINT-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-04-06 | 2018-08-22 | 45124 |
MINT-PANTOPRAZOLE | 40MG | TABLET (DELAYED-RELEASE) | Resolved | 2018-04-06 | 2018-10-17 | 45121 |
MINT-CLOPIDOGREL | 75MG | TABLET | Actual shortage | 2018-04-06 | 2018-04-07 | 45117 |
MINT-CLOPIDOGREL | 75MG | TABLET | Actual shortage | 2018-03-09 | 2018-03-10 | 42370 |
MINT-DORZOLAMIDE/TIMOLOL | 5MG 20MG | SOLUTION | Resolved | 2018-01-11 | 2018-09-19 | 35753 |
MINT-PREGABALIN | 50MG | CAPSULE | Resolved | 2018-01-09 | 2018-03-17 | 35501 |
MINT-PREGABALIN | 25MG | CAPSULE | Resolved | 2018-01-09 | 2018-02-03 | 35498 |
MINT-SOLIFENACIN | 10MG | TABLET | Resolved | 2018-01-09 | 2018-03-21 | 35495 |
MINT-SOLIFENACIN | 5MG | TABLET | Resolved | 2018-01-09 | 2018-03-21 | 35492 |
MINT-SIMVASTATIN | 80MG | TABLET | Resolved | 2018-01-09 | 2018-02-15 | 35489 |
MINT-SIMVASTATIN | 5MG | TABLET | Resolved | 2018-01-09 | 2018-02-15 | 35486 |
MINT-SERTRALINE | 25MG | CAPSULE | Resolved | 2018-01-09 | 2018-03-09 | 35483 |
MINT-PAROXETINE | 20MG | TABLET | Resolved | 2018-01-09 | 2018-03-03 | 35480 |
MINT-PAROXETINE | 10MG | TABLET | Resolved | 2018-01-09 | 2018-04-12 | 35476 |
MINT-OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-09 | 2018-07-25 | 35473 |
MINT-OLANZAPINE ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-09 | 2018-07-25 | 35470 |
MINT-OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-01-09 | 2018-07-25 | 35467 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58286 |
MINT-CLOPIDOGREL | 75MG | TABLET | Discontinued | 2018-08-16 | 2018-08-17 | 58283 |
MINT-RIVASTIGMINE | 4.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13565 |
MINT-RIVASTIGMINE | 1.5MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13562 |
MINT-RIVASTIGMINE | 6MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13559 |
MINT-RIVASTIGMINE | 3MG | CAPSULE | Discontinued | 2017-06-21 | 2017-07-01 | 13556 |
MINT-RIZATRIPTAN ODT | 10MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13553 |
MINT-RIZATRIPTAN ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13544 |
MINT-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2017-06-21 | 2017-07-01 | 13540 |